A discussion with Dr. Igor Mikaelian from AbbVie Bioresearch in Worcester MA about special issue 4 that focuses on drug induced vascular injury. The discussion centers on why drug-induced vascular injury in animals is an issue, why is it important when developing new pharmaceuticals, what efforts are underway to address human risk assessment of vascular injury, and how the articles in this issue benefit the pharmaceutical and biotech industries.

Click here to read the full article.